Search Results - "Zarmpi, P."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Biopharmaceutical aspects and implications of excipient variability in drug product performance by Zarmpi, P., Flanagan, T., Meehan, E., Mann, J., Fotaki, N.

    “…[Display omitted] Implementation of Quality by Design approaches in pharmaceutical industry requires a sound understanding of the parameters triggering final…”
    Get full text
    Journal Article
  2. 2

    Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution by Zarmpi, P., Flanagan, T., Meehan, E., Mann, J., Fotaki, N.

    Published in International journal of pharmaceutics (15-03-2020)
    “…[Display omitted] Superdisintegrants are a key excipient used in immediate release formulations to promote fast tablet disintegration, therefore understanding…”
    Get full text
    Journal Article
  3. 3

    Impact of Magnesium Stearate Presence and Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties by Zarmpi, P., Flanagan, T., Meehan, E., Mann, J., Fotaki, Nikoletta

    Published in The AAPS journal (21-05-2020)
    “…Excipients are major components of oral solid dosage forms, and changes in their critical material attributes (excipient variability) and/or amount (excipient…”
    Get full text
    Journal Article
  4. 4

    Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products by Zarmpi, P., Flanagan, T., Meehan, E., Mann, J., Østergaard, J., Fotaki, N.

    “…[Display omitted] Elucidating the impact of excipient variability on oral product performance in a biopharmaceutical perspective would be beneficial and allow…”
    Get full text
    Journal Article
  5. 5

    Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study—Hypromellose (HPMC) by Zarmpi, P., Flanagan, T., Meehan, E., Mann, J., Fotaki, N.

    Published in The AAPS journal (18-02-2020)
    “…Identification of the biopharmaceutical risks of excipients and excipient variability on oral drug performance can be beneficial for the development of robust…”
    Get full text
    Journal Article